Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor necrosis factor alpha (TNF-α) signaling pathway is a central regulator of inflammation, immunity, cell survival, and apoptosis. TNF-α is a pro-inflammatory cytokine that exerts its effects primarily through two receptors: TNFR1 and TNFR2. The pathway branches into several major outcomes, including apoptosis, cell survival, and inflammation. Excessive or dysregulated TNF signaling contributes to autoimmune and inflammatory diseases. Therapeutic agents targeting this pathway are widely used for conditions like rheumatoid arthritis and Crohn’s disease.
Inhibition of TNF-α signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Alpha Signaling Pathway (None).